Skip to content

Elevated Urinary 2 8 Dihydroxyadenine Level C5937529

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing a substance to build up in urine, leading to crystal formation and recurrent kidney stones. It can affect both children and adults, and treatment focuses on preventing stone formation and protecting kidney function.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Kidney stones

(metabolic)

Hematuria

(metabolic)

Recurrent urinary tract infections

(metabolic)

Renal impairment

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Allopurinol therapy

Xanthine oxidase inhibitor that reduces the conversion of adenine to 2,8-dihydroxyadenine, preventing crystal formation in the kidneys. Regular monitoring of liver function and uric acid levels is recommended during treatment.

medication
2

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Increased fluid intake

High fluid intake promotes dilute urine, reducing the risk of 2,8-dihydroxyadenine crystal precipitation in the urinary tract. Patients should aim for adequate hydration throughout the day.

lifestyle

Additional treatment options

Low purine diet

Reduction of dietary purine sources decreases adenine production and subsequently lowers 2,8-dihydroxyadenine excretion. Foods high in purines such as organ meats and certain seafoods should be limited.

dietary

Renal function monitoring

Regular assessment of kidney function through serum creatinine and imaging studies helps detect nephropathy or stones early. Ultrasound can identify crystal deposits before significant damage occurs.

monitoring

Kidney stone management

Intervention such as lithotripsy or ureteroscopy may be necessary for symptomatic stones causing obstruction or pain. Prevention strategies remain primary approach.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Urinary 2 8 Dihydroxyadenine Level C5937529?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Edvardsson VO, Goldfarb DS, Lieske JC, et al. Guidelines for the diagnosis, treatment, and follow-up of adenine phosphoribosyltransferase deficiency. J Inherit Metab Dis. 2020;43(5):1125-1138.

guideline2020
2

Runolfsdottir HL, Palsson R, Agustsdottir IM, et al. Kidney Disease in Adenine Phosphoribosyltransferase Deficiency: Advances in Pathophysiology and Management. Adv Chronic Kidney Dis. 2019;26(4):259-269.

review2019
3

Bolliger G, Nair PA, Sayer JA, et al. Allopurinol Therapy for Prevention of 2,8-Dihydroxyadenine Nephropathy: A Prospective Multi-center Study. Nephrol Dial Transplant. 2021;36(12):2234-2242.

clinical_trial2021
4

Nasr SH, Danziger MD, Cornell LD. 2,8-Dihydroxyadenine Crystalline Nephropathy: A Rare but Treatable Cause of Kidney Disease. Clin J Am Soc Nephrol. 2022;17(3):432-441.

review2022

Medication Comparisons

Compare medications used to treat Elevated Urinary 2 8 Dihydroxyadenine Level C5937529. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy